Table of Contents
Print

What is Viloxazine (Qelbree)? 

Viloxazine (brand name Qelbree) is a non-stimulant medication approved for the treatment of ADHD in children and adolescents aged 6 to 17. It offers a new approach to managing ADHD, especially for those who may not respond well to stimulant medications or experience undesirable side effects. 

Mechanism of Action 

Viloxazine (Qelbree) for ADHD works by modulating norepinephrine and serotonin in the brain. While stimulants primarily increase dopamine and norepinephrine, Viloxazine targets both norepinephrine and serotonin systems, helping improve attention, impulse control, and emotional regulation. This mechanism of action is thought to provide a steady, long-lasting effect without the immediate high or low associated with stimulant medications. 

Non-Stimulant Option for ADHD 

As a non-stimulant medication, Viloxazine (Qelbree) for ADHD is an attractive option for individuals who have concerns about the potential for stimulant misuse or side effects, such as insomnia or appetite loss. It offers an alternative for managing ADHD symptoms with a different pharmacological approach, helping reduce hyperactivity, impulsivity, and inattention. 

Side Effects and Benefits 

The side effect profile of Viloxazine is generally milder compared to stimulants. Some common side effects include decreased appetite, fatigue, and irritability, but these are often less severe than those experienced with stimulants. Additionally, Viloxazine does not carry the risk of abuse or addiction, making it a safer choice for long-term use. 

In conclusion, Viloxazine (Qelbree) is an effective non-stimulant medication for ADHD that offers an alternative for individuals who need continuous symptom management without the side effects of stimulants. 

Visit providers like ADHD Certify for personal consultations and expert guidance tailored to your unique situation. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medications for ADHD.

Avery Lombardi, MSc, author for my patient advice - mypatientadvice.co.uk

Avery Lombardi, MSc

Author

Avery Lombardi is a clinical psychologist with a Master’s in Clinical Psychology and a Bachelor’s in Psychology. She has professional experience in psychological assessment, evidence-based therapy, and research, working with both child and adult populations. Avery has provided clinical services in hospital, educational, and community settings, delivering interventions such as CBT, DBT, and tailored treatment plans for conditions including anxiety, depression, and developmental disorders. She has also contributed to research on self-stigma, self-esteem, and medication adherence in psychotic patients, and has created educational content on ADHD, treatment options, and daily coping strategies.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Rebecca Fernandez, MBBS, author and a reviewer for my patient advice - mypatientadvice.co.uk

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.